NSE filing, NSE: VINCOFE. Summary written from the filing by ALFA Finder's alert engine.
Vintage Coffee And Beverages Ltd: key numbers
- Share price
- ₹159.95
- Market cap
- ₹2,310 Cr
- Revenue (annual)
- ₹316.6 Cr
- Net profit (annual)
- ₹13.75 Cr
- P/E (TTM)
- 61.5×Sector 47.2×
- Promoter holding
- 35.01%+0.36% QoQ
- FII holding
- 4.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vintage Coffee And Beverages Ltd
All →Vintage Coffee And Beverages Earnings Call Transcript: Key Takeaways
Q2 revenue rose 64.4% YoY to ₹222.97 Cr and PAT 57.3% to ₹28.06 Cr, led by volume. Management deflected on equity dilution and the freeze-dried (FDC) start date, which slipped 1-2 months.
Vintage Coffee And Beverages Results Update
Vintage Coffee and Beverages issued a press release highlighting Q2 FY27 consolidated revenue of Rs 222.97 Crore, up 64%. Half-year PAT rose 52% to Rs 48.85 Crore.
Vintage Coffee And Beverages Q2 FY27 Results: Net Profit ₹28.1 Cr, Up 57.9% YoY
Vintage Coffee And Beverages Ltd reported revenue from operations of ₹223 Cr (+64.5% YoY) and net profit of ₹28.1 Cr (+57.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹28.1 Cr · +57.9% YoY
Vintage Coffee And Beverages Acquisition
Vintage Coffee and Beverages Ltd confirmed that its wholly owned subsidiaries Vintage Coffee Private Limited and Delecto Foods Private Limited were amalgamated into the company. Consequently, the company no longer has any subsidiaries.
Vintage Coffee And Beverages Board Meeting Date
Vintage Coffee scheduled a board meeting on 4 November 2026 to consider quarter and half-year results. No financial figures are disclosed yet.
Vintage Coffee And Beverages Fund Raise of ₹325 Cr
Vintage Coffee and Beverages Limited's board approved raising funds up to Rs. 325 Crores through various securities. The board also enhanced borrowing and investment limits.
- Value
- ₹325.0 Cr
Other product launch announcements
All →AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum
Restaurant Brands Asia Product Launch
Burger King India launches a limited-edition Avengers: Doomsday Collection across nationwide restaurants. The menu features themed burgers, sides, and merchandise starting at ₹199.
Hero MotoCorp Product Launch
Hero MotoCorp unveiled new motorcycles at EICMA 2026 and started VIDA customer deliveries across Europe. The company also introduced Novus Labs, its future-mobility innovation hub.